回復期血漿療法の世界市場レポート 2025年

回復期血漿療法の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR13.7％で9,000万米ドルに成長します。予測期間の成長は、病原体の進化、免疫療法の開発、規制の枠組み、世界の備え、公衆衛生への取り組みに起因しています。予測期間の主な動向には、標準化された収集と処理、標的血漿成分、個別化治療、遠隔医療と遠隔モニタリング、長期的効果の調査などがあります。

COVID-19患者における回復期血漿療法（CPT）の臨床試験で実証された高い有効性と安全性が、予測期間における市場成長の原動力になると予想されます。回復期血漿療法は、SARS-1、中東呼吸器症候群（MERS）、2009 H1N1など、さまざまな感染症の流行時に注目されてきました。2022年6月にヒューストン・メソジスト病院が実施した研究のような結果が、その可能性を裏付けています。この研究では、回復期血漿療法の安全性（有害事象の報告なし）と効率性の両方が示され、COVID-19患者の76％の回復率が示されました。さらに、2020年5月にJournal of Medical Virology誌に掲載された研究では、回復期血漿療法が重症患者の死亡率を低下させ、臨床症状を緩和し、中和抗体価の上昇とSARS-CoV-2 RNAの消失につながる可能性があることが明らかになりました。これらの研究により、COVID-19治療におけるCPTの安全性と有効性が確認されたことから、世界の回復期血漿療法市場は、効果が証明された治療に対する継続的な需要に牽引され、成長するものと思われます。

病院数の増加が回復期血漿療法市場の成長を促進すると予想されます。ヘルスケアは、診断、治療、患者のケアなど、幅広いヘルスケアサービスを提供する専用の医療施設です。病院数の増加はしばしば医療インフラの改善を示し、回復期血漿の収集、処理、投与のためのより良い施設を提供します。例えば、スコットランド公衆衛生局が2022年9月に発表した報告書によると、急性期専門科の有床診療所が増加し、2021/22年には平均13,323床となり、前年（2020/21年）から3.6％増加します。稼働率は2020-21年の74.8%から2021/22年には84.2%に上昇し、ヘルスケア施設の増加を示しています。したがって、病院数の急増は回復期血漿療法市場の重要な促進要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界回復期血漿療法PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の回復期血漿療法市場：成長率分析
• 世界の回復期血漿療法市場の実績：規模と成長, 2019-2024
• 世界の回復期血漿療法市場の予測：規模と成長, 2024-2029, 2034F
• 世界回復期血漿療法総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の回復期血漿療法市場抗体の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫グロブリンM（IgM）
• 免疫グロブリンG（IgG）
• 免疫グロブリンA
• 世界の回復期血漿療法市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 予防
• 治療
• 世界の回復期血漿療法市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 研究所および調査機関
• 世界の回復期血漿療法市場IgMのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染初期段階の血漿
• 急性期血漿
• その他のIgMベースの血漿製品
• 世界の回復期血漿療法市場IgGのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 高力価IgG血漿
• 標準IgG血漿
• その他のIgGベースの血漿製品
• 世界の回復期血漿療法市場IgAのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• IgAを豊富に含む血漿
• 特異的IgA抗体血漿
• その他のIgAベースの血漿製品

第7章 地域別・国別分析

• 世界の回復期血漿療法市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の回復期血漿療法市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 回復期血漿療法市場：競合情勢
• 回復期血漿療法市場：企業プロファイル
  • Bio Farma Overview, Products and Services, Strategy and Financial Analysis
  • Hilton Pharma Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Biotest AG Overview, Products and Services, Strategy and Financial Analysis
  • BPL Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • LFB SA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Octapharma AG
• CSL Behring LLC
• Takeda Pharmaceutical Company Ltd.
• Orthosera Kft.
• ADMA Biologics Inc.
• GC Biopharma Corp
• Grifols S.A
• Sanquin Plasma Products B.V.
• America's Blood Centers
• Blood Centers of America Inc.
• Anthem Inc.
• Laboratory Corporation of America Holdings
• Cerus Corporation
• Emergent BioSolutions Inc.
• Kedrion Biopharma Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 回復期血漿療法市場2029：新たな機会を提供する国
• 回復期血漿療法市場2029：新たな機会を提供するセグメント
• 回復期血漿療法市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Convalescent plasma refers to plasma obtained from individuals who have recuperated from an infection and contains antibodies targeting the specific microorganism responsible for the infection. It is employed in the treatment of patients afflicted by the same pathogen.

The principal antibody categories utilized in convalescent plasma therapy are Immunoglobulin M (IgM), Immunoglobulin G (IgG), and Immunoglobulin A (IgA). Immunoglobulin A (IgA) is a crucial antibody for immune activities within mucous membranes. Convalescent plasma finds various applications, including preventive measures (prophylaxis) and treatment, and is applied across a range of sectors, including hospitals, clinics, laboratories, and research institutes.

The convalescent plasma therapy market research report is one of a series of new reports from The Business Research Company that provides convalescent plasma therapy market statistics, including convalescent plasma therapy industry global market size, regional shares, competitors with a convalescent plasma therapy market share, detailed convalescent plasma therapy market segments, market trends and opportunities, and any further data you may need to thrive in the convalescent plasma therapy industry. This convalescent plasma therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The convalescent plasma therapy market size has grown rapidly in recent years. It will grow from $0.05 billion in 2024 to $0.06 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to pandemics and infectious disease outbreaks, immunotherapy research, emergency use authorization (eua), patient availability, clinician and public awareness.

The convalescent plasma therapy market size is expected to see rapid growth in the next few years. It will grow to $0.09 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to evolving pathogens, immunotherapies development, regulatory frameworks, global preparedness, public health initiatives. Major trends in the forecast period include standardized collection and processing, targeted plasma components, personalized treatment, telemedicine and remote monitoring, research into long-term effects.

Higher efficacy and safety demonstrated during trials for convalescent plasma therapy (CPT) in COVID-19 patients are expected to drive market growth in the forecast period. Convalescent plasma therapy has been a subject of interest during various infectious disease outbreaks, such as SARS-1, Middle East Respiratory Syndrome (MERS), and 2009 H1N1. The results from studies, like the one conducted by Houston Methodist Hospital in June 2022, support its potential. The study indicated that convalescent plasma therapy was both safe (with no reported adverse events) and efficient, showing a 76% recovery rate for COVID-19 patients. In addition, a study published in the Journal of Medical Virology in May 2020 found that convalescent plasma therapy could potentially reduce mortality rates in critically ill patients, alleviate clinical symptoms, and lead to an increase in neutralizing antibody titers and the disappearance of SARS-CoV-2 RNA. As these studies confirm the safety and efficacy of CPT in treating COVID-19, the global convalescent plasma therapy market is poised for growth, driven by ongoing demand for treatments with proven benefits.

The increase in the number of hospitals is expected to propel the growth of the convalescent plasma therapy market. Hospitals are dedicated medical facilities providing a wide range of healthcare services, including diagnosis, treatment, and patient care. The rise in the number of hospitals often indicates improved healthcare infrastructure, offering better facilities for collecting, processing, and administering convalescent plasma. For instance, a report by Public Health Scotland in September 2022 indicated an increase in staffed beds for acute specialties, reaching an average of 13,323 in 2021/22, a 3.6% increase from the previous year (2020/21). Increased occupancy rates from 74.8% in 2020-21 to 84.2% in 2021/22 signify the growth in healthcare facilities. Therefore, the surge in hospital numbers is a key driver of the convalescent plasma therapy market.

The development of antibody-based immunotherapy for COVID-19 presents opportunities for the convalescent plasma therapy market. This therapy, which utilizes antibodies to enhance a patient's immunity, has garnered attention from companies investing in antibody-based COVID-19 treatments. For example, Regeneron Pharmaceuticals Inc. collaborated with the Biomedical Advanced Research and Development Authority (BARDA) to develop next-generation COVID-19 monoclonal antibody therapy. This focus on antibody-based COVID-19 therapy is likely to boost the convalescent plasma therapy market.

Major companies in the convalescent plasma therapy market are focusing on the development of innovative solutions, such as hyperimmune globulin therapies, to improve treatment efficacy and overcome the limitations of standard plasma therapies. Hyperimmune globulin therapies involve the use of plasma that is enriched with specific antibodies, typically collected from individuals who have recovered from a particular infection, offering potent and targeted immune support for patients. For example, in October 2023, Kamada Ltd., an Israel-based biopharmaceutical company, announced significant progress with its product CYTOGAM (Cytomegalovirus Immune Globulin Intravenous [Human]). After receiving FDA approval for its manufacturing facility in Israel, CYTOGAM became commercially available in the U.S. New clinical data presented at IDWeek 2023 revealed a five-year survival benefit for high-risk cytomegalovirus (CMV) mismatch lung transplant patients who received CYTOGAM. Additionally, Kamada formed its first Scientific Advisory Board to further enhance its U.S. clinical programs, positioning the company to make strides in the development of hyperimmune globulin therapies as a treatment for various infectious diseases. This move highlights the potential of hyperimmune globulin treatments to enhance convalescent plasma therapy and offer targeted, effective care for patients.

Major companies operating in the convalescent plasma therapy market include Bio Farma, Hilton Pharma Ltd., Biotest AG, BPL Ltd., LFB SA, Octapharma AG, CSL Behring LLC, Takeda Pharmaceutical Company Ltd., Orthosera Kft., ADMA Biologics Inc., GC Biopharma Corp, Grifols S.A, Sanquin Plasma Products B.V., America's Blood Centers, Blood Centers of America Inc., Anthem Inc., Laboratory Corporation of America Holdings, Cerus Corporation, Emergent BioSolutions Inc., Kedrion Biopharma Inc., New York Blood Center, Blood Systems Inc., OneBlood Inc., Gulf Coast Regional Blood Center, Bloodworks Northwest, Blood Assurance Inc., New York Blood Center Inc., Honolulu Blood-Plasma Bank, Community Blood Center, LifeStream Blood Bank

North America was the largest region in the convalescent plasma therapy market in 2024. Western Europe was the second largest region in the convalescent plasma therapy market. The regions covered in the convalescent plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the convalescent plasma therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The convalescent plasma therapy market includes revenue earned by IgD and IgE. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Convalescent Plasma Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on convalescent plasma therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for convalescent plasma therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The convalescent plasma therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Antibody type: IgM; IgG; IgA
• 2) By Application: Prophylaxis; Treatment
• 3) By End-Users: Hospitals And Clinics; Laboratories And Research institutes
• Subsegments:
• 1) By IgM: Early-Stage Infection Plasma; Acute Phase Plasma; Other IgM-Based Plasma Products
• 2) By IgG: High Titer IgG Plasma; Standard IgG Plasma; Other IgG-Based Plasma Products
• 3) By IgA: Plasma Rich In IgA; Specific IgA Antibody Plasma; Other IgA-Based Plasma Products
• Companies Mentioned: Bio Farma; Hilton Pharma Ltd.; Biotest AG; BPL Ltd.; LFB SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Convalescent Plasma Therapy Market Characteristics

3. Convalescent Plasma Therapy Market Trends And Strategies

4. Convalescent Plasma Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Convalescent Plasma Therapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Convalescent Plasma Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Convalescent Plasma Therapy Market Growth Rate Analysis
• 5.4. Global Convalescent Plasma Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Convalescent Plasma Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Convalescent Plasma Therapy Total Addressable Market (TAM)

6. Convalescent Plasma Therapy Market Segmentation

• 6.1. Global Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoglobulin M (IgM)
• Immunoglobulin G (IgG)
• Immunoglobulin A
• 6.2. Global Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prophylaxis
• Treatment
• 6.3. Global Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Laboratories And Research Institutes
• 6.4. Global Convalescent Plasma Therapy Market, Sub-Segmentation Of IgM, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Early-Stage Infection Plasma
• Acute Phase Plasma
• Other IgM-Based Plasma Products
• 6.5. Global Convalescent Plasma Therapy Market, Sub-Segmentation Of IgG, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High Titer IgG Plasma
• Standard IgG Plasma
• Other IgG-Based Plasma Products
• 6.6. Global Convalescent Plasma Therapy Market, Sub-Segmentation Of IgA, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plasma Rich In IgA
• Specific IgA Antibody Plasma
• Other IgA-Based Plasma Products

7. Convalescent Plasma Therapy Market Regional And Country Analysis

• 7.1. Global Convalescent Plasma Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Convalescent Plasma Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Convalescent Plasma Therapy Market

• 8.1. Asia-Pacific Convalescent Plasma Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Convalescent Plasma Therapy Market

• 9.1. China Convalescent Plasma Therapy Market Overview
• 9.2. China Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Convalescent Plasma Therapy Market

• 10.1. India Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Convalescent Plasma Therapy Market

• 11.1. Japan Convalescent Plasma Therapy Market Overview
• 11.2. Japan Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Convalescent Plasma Therapy Market

• 12.1. Australia Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Convalescent Plasma Therapy Market

• 13.1. Indonesia Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Convalescent Plasma Therapy Market

• 14.1. South Korea Convalescent Plasma Therapy Market Overview
• 14.2. South Korea Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Convalescent Plasma Therapy Market

• 15.1. Western Europe Convalescent Plasma Therapy Market Overview
• 15.2. Western Europe Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Convalescent Plasma Therapy Market

• 16.1. UK Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Convalescent Plasma Therapy Market

• 17.1. Germany Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Convalescent Plasma Therapy Market

• 18.1. France Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Convalescent Plasma Therapy Market

• 19.1. Italy Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Convalescent Plasma Therapy Market

• 20.1. Spain Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Convalescent Plasma Therapy Market

• 21.1. Eastern Europe Convalescent Plasma Therapy Market Overview
• 21.2. Eastern Europe Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Convalescent Plasma Therapy Market

• 22.1. Russia Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Convalescent Plasma Therapy Market

• 23.1. North America Convalescent Plasma Therapy Market Overview
• 23.2. North America Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Convalescent Plasma Therapy Market

• 24.1. USA Convalescent Plasma Therapy Market Overview
• 24.2. USA Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Convalescent Plasma Therapy Market

• 25.1. Canada Convalescent Plasma Therapy Market Overview
• 25.2. Canada Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Convalescent Plasma Therapy Market

• 26.1. South America Convalescent Plasma Therapy Market Overview
• 26.2. South America Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Convalescent Plasma Therapy Market

• 27.1. Brazil Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Convalescent Plasma Therapy Market

• 28.1. Middle East Convalescent Plasma Therapy Market Overview
• 28.2. Middle East Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Convalescent Plasma Therapy Market

• 29.1. Africa Convalescent Plasma Therapy Market Overview
• 29.2. Africa Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Convalescent Plasma Therapy Market Competitive Landscape And Company Profiles

• 30.1. Convalescent Plasma Therapy Market Competitive Landscape
• 30.2. Convalescent Plasma Therapy Market Company Profiles
  • 30.2.1. Bio Farma Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Hilton Pharma Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Biotest AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. BPL Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. LFB SA Overview, Products and Services, Strategy and Financial Analysis

31. Convalescent Plasma Therapy Market Other Major And Innovative Companies

• 31.1. Octapharma AG
• 31.2. CSL Behring LLC
• 31.3. Takeda Pharmaceutical Company Ltd.
• 31.4. Orthosera Kft.
• 31.5. ADMA Biologics Inc.
• 31.6. GC Biopharma Corp
• 31.7. Grifols S.A
• 31.8. Sanquin Plasma Products B.V.
• 31.9. America's Blood Centers
• 31.10. Blood Centers of America Inc.
• 31.11. Anthem Inc.
• 31.12. Laboratory Corporation of America Holdings
• 31.13. Cerus Corporation
• 31.14. Emergent BioSolutions Inc.
• 31.15. Kedrion Biopharma Inc.

32. Global Convalescent Plasma Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Convalescent Plasma Therapy Market

34. Recent Developments In The Convalescent Plasma Therapy Market

35. Convalescent Plasma Therapy Market High Potential Countries, Segments and Strategies

• 35.1 Convalescent Plasma Therapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Convalescent Plasma Therapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Convalescent Plasma Therapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer